Q4 2021 G1 Therapeutics Inc Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to G1 Therapeutics Fourth Quarter 2021 Financial Results Conference Call. (Operator Instructions)
I would now like to turn the conference over to your host today, Will Roberts, Head of Corporate Communications. Sir, please go ahead.
Thanks, Joanna. Good morning, everyone, and welcome to the G1 conference call to discuss our fourth quarter 2021 financial results and business update. The press release on these financial results was issued this morning and can be found in the News section of our corporate website, g1therapeutics.com.
On this morning's call, the team will provide a business overview of the fourth quarter and full year of 2021 including an update on our clinical programs and our commercial progress in that period with COSELA, which is approved by the U.S. Food and Drug Administration to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior to a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |